Abstract
Understanding of the signal transduction pathways that lead to B cell development is of extreme interest to learn how alterations in these pathways might initiate malignant transformation. Long-term cultured early pre-BI cells can differentiate into IgM+ B cells after transplant into NOD/SCID mice, offering the possibility to explore checkpoints in B cell development. Using DNA microarray and Western blot analysis of IgM+ B cells vs parental early pre-BI cells, we demonstrated that zeta-associated protein 70 (ZAP-70) is upregulated in our B cell differentiation model. Unlike parental ZAP-70− early pre-BI cells, ZAP-70+ IgM+ B cells exhibited a transformed phenotype, as indicated by BCL-6 expression, a high Ki-67 proliferation index, resistance to IL-7 deprivation-induced apoptosis, and an increased repopulation rate in NOD/SCID mice. These data show the characterization and generation of a novel murine leukemia model with many similarities to human ZAP-70+ B cell chronic lymphocytic leukemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Astsaturov IA, Samoilova RS, Iakhnina EI, Pivnik AV and Vorobiov AI . (1997). Leuk. Lymphoma, 26, 337–342.
Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, van der Valk M, te Riele H, Berns A and Murre C . (1994). Cell, 79, 885–892.
Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, Clark EA and Weiss A . (1994). J. Immunol., 152, 4758–4766.
Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A and Kipps TJ . (2002). Blood, 100, 4609–4614.
Cordone I, Matutes E and Catovsky D . (1992). Leukemia, 6, 902–906.
Hardy RR, Carmack CE, Shinton SA, Kemp JD and Hayakawa K . (1991). J. Exp. Med., 173, 1213–1225.
Hunte BE, Capone M, Zlotnik A, Rennick D and Moore TA . (1998). Eur. J. Immunol., 28, 3850–3856.
Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM and Albitar M . (2001). Blood, 98, 181–186.
Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A and Dalla-Favera R . (2001). J. Exp. Med., 194, 1625–1638.
Kozmik Z, Wang S, Dorfler P, Adams B and Busslinger M . (1992). Mol. Cell. Biol., 12, 2662–2672.
Lin H and Grosschedl R . (1995). Nature, 376, 263–267.
Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL . (1996). Nat. Biotechnol., 14, 1675–1680.
Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H and Baltimore D . (1989). Cell, 58, 537–544.
Musto P, Melillo L, Lombardi G, Aieta M, Di Renzo N and Carotenuto M . (1990). Haematologica, 75, 583–584.
Niu H, Ye BH and Dalla-Favera R . (1998). Genes Dev., 12, 1953–1961.
O'Riordan M and Grosschedl R . (2000). Immunol. Rev., 175, 94–103.
Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H and Mori S . (1995). Blood, 86, 28–37.
Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM and Oscier DG . (2004). Lancet, 363, 105–111.
Pardal R, Clarke MF and Morrison SJ . (2003). Nat. Rev. Cancer, 3, 895–902.
Ranheim EA, Cantwell MJ and Kipps TJ . (1995). Blood, 85, 3556–3565.
Rolink A, Grawunder U, Winkler TH, Karasuyama H and Melchers F . (1994). Int. Immunol., 6, 1257–1264.
Rolink A and Melchers F . (1991). Cell, 66, 1081–1094.
Rolink A, ten Boekel E, Melchers F, Fearon DT, Krop I and Andersson J . (1996). J. Exp. Med., 183, 187–194.
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO and Staudt LM . (2001). J. Exp. Med., 194, 1639–1647.
Ruiz-Vela A, Serrano F, Gonzalez MA, Abad JL, Bernad A, Maki M and Martinez AC . (2001). J. Exp. Med., 194, 247–254.
Stamenkovic I and Seed B . (1988). J. Exp. Med., 168, 1205–1210.
Zhuang Y, Soriano P and Weintraub H . (1994). Cell, 79, 875–884.
Acknowledgements
We thank the technical staff of the department who aid with cell culture and materials preparation, and C Mark for editorial assistance. The Department of Immunology and Oncology was founded and is supported by the Spanish National Research Council (CSIC) and by Pfizer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruiz-Vela, A., Piqueras, R., Carvalho-Pinto, C. et al. ZAP-70 upregulation in transformed B cells after early pre-BI cell transplant into NOD/SCID mice. Oncogene 24, 5119–5124 (2005). https://doi.org/10.1038/sj.onc.1208706
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208706